Tenaya Therapeutics Inc(TNYA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TNYA Tenaya Therapeutics Inc

盘后交易 10-07 17:18:43 EDT

0.5334

-0.0131

-2.40%

盘后0.5400

+0.0066+1.24%

17:18 EDT

最高0.5548	最低0.5300	成交量371.46万
今开0.5300	昨收0.5465	日振幅4.54%
总市值1.19亿	流通市值1.19亿	总股本2.24亿
成交额200.32万	换手率1.67%	流通股本2.23亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TNYA","market":"US","secType":"STK","nameCN":"Tenaya Therapeutics Inc","latestPrice":0.5334,"timestamp":1791403200000,"preClose":0.5465,"halted":0,"volume":3714596,"hourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.5334,"latestTime":"17:18 EDT","volume":13097,"amount":7199.2598069,"timestamp":1791407915534,"change":0.0066,"changeRate":0.012373,"amplitude":0.035996},"delay":0,"changeRate":-0.023970722781335774,"floatShares":223000000,"shares":224000000,"eps":-0.533312,"marketStatus":"盘后交易","change":-0.0131,"latestTime":"10-07 17:18:43 EDT","open":0.53,"high":0.5548,"low":0.53,"amount":2003249.3058148,"amplitude":0.04538,"askPrice":0.5937,"askSize":100,"bidPrice":0.53,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.533312,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791417600000},"marketStatusCode":4,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":0.5465,"preHourTrading":{"tag":"盘前","latestPrice":0.542,"preClose":0.5465,"latestTime":"09:18 EDT","volume":29694,"amount":16262.42300718,"timestamp":1791379095857,"change":-0.0045,"changeRate":-0.008234,"amplitude":0.047575},"postHourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.5334,"latestTime":"17:18 EDT","volume":13097,"amount":7199.2598069,"timestamp":1791407915534,"change":0.0066,"changeRate":0.012373,"amplitude":0.035996},"volumeRatio":1.170393,"impliedVol":1.1079,"impliedVolPercentile":0.3187},"requestUrl":"/m/hq/s/TNYA","defaultTab":"news","newsList":[{"id":"1198878695","title":"Tenaya Therapeutics获美国FDA再生医学先进疗法认定：TN-401治疗PKP2相关致心律失常性右心室心肌病","url":"https://stock-news.laohu8.com/highlight/detail?id=1198878695","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198878695?lang=zh_cn&edition=full","pubTime":"2026-09-14 20:30","pubTimestamp":1789389031,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics公司宣布，其研发的TN-401疗法已获得美国食品药品监督管理局授予的再生医学先进疗法资格认定。该疗法旨在治疗与PKP2基因突变相关的致心律失常性右心室心肌病。获得此项资格后，Tenaya Therapeutics将享有与FDA更紧密的沟通协作机会，并有望通过优先审评渠道缩短产品开发周期。Tenaya Therapeutics表示，RMAT资格的授予不仅肯定了TN-401在临床前及早期临床研究中展现的潜力，也反映了FDA对推动创新疗法以解决未满足医疗需求的积极态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105047137","title":"新闻稿：Tenaya Therapeutics任命Eric Hyllengren为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1105047137","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105047137?lang=zh_cn&edition=full","pubTime":"2026-06-29 20:31","pubTimestamp":1782736275,"startTime":"0","endTime":"0","summary":"2026年6月29日，临床阶段生物技术公司Tenaya Therapeutics Inc宣布，任命Eric Hyllengren为首席财务官，自2026年7月13日起生效。履新后，Hyllengren将负责公司的财务战略、资本配置、投资者关系以及企业发展事务。Tenaya同时宣布，公司高级副总裁、财务负责人Hiro Higa将于2026年第三季度退休。Tenaya Therapeutics是一家临床阶段的生物技术公司，致力于一项宏伟使命：发现、开发和提供针对心脏病根本驱动因素的潜在治愈性疗法。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","HCM","BK4585","BK4139","BK4007","BK4539","BK4588","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117050360","title":"Tenaya Therapeutics：所有可评估患者在Tn-201治疗后，Mybpc3相关HCM均显示改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1117050360","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117050360?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:06","pubTimestamp":1780484799,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics公司宣布，在其候选疗法Tn-201的临床研究中，所有可评估的Mybpc3基因相关肥厚型心肌病患者均显示出病情改善。这一积极数据为治疗这一严重遗传性心脏病带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TNYA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198463241","title":"Tenaya Therapeutics - 队列1获益持续长达两年；队列2显示更早改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1198463241","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198463241?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:03","pubTimestamp":1780484593,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics公司公布的最新数据显示，其疗法在两项患者队列中展现出积极且持久的临床效果。\n第一队列的患者获益得以持续长达两年之久，凸显了该疗法的长期潜力与稳定性。与此同时，第二队列的数据则传递出更为鼓舞人心的信号：患者表现出更早的临床改善。这一发现可能意味着该疗法在疾病进程的较早阶段介入，能带来更显著的治疗反应，为未来的应用策略提供了关键见解。\n两项结果共同指向了该疗法的积极前景，后续进展值得持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165666908","title":"Tenaya Therapeutics公布Mypeak™-1中期数据：Tn-201基因疗法治疗Mybpc3相关HCM显示心脏重构迹象与症状减轻","url":"https://stock-news.laohu8.com/highlight/detail?id=1165666908","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165666908?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:01","pubTimestamp":1780484483,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics公司公布了其Mypeak™-1研究的中期数据。数据显示，使用Tn-201基因疗法治疗与Mybpc3基因相关的肥厚型心肌病，已观察到持续的心脏重构迹象，并伴随患者症状的减轻。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TNYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178770965","title":"Tenaya Therapeutics将于2026年6月3日公布Tn-201治疗成人Mybpc3相关HCM的Mypeak™-1期1B/2期试验新中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1178770965","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178770965?lang=zh_cn&edition=full","pubTime":"2026-06-03 04:31","pubTimestamp":1780432282,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc  计划于2026年6月3日（星期三）公布其候选药物Tn-201在Mypeak-1 1B/2期临床试验中的新中期数据。该试验旨在评估Tn-201用于治疗成人MYBPC3基因相关肥厚型心肌病患者的疗效与安全性。肥厚型心肌病是一种以心肌异常增厚为特征的疾病，而MYBPC3基因突变是其常见的遗传病因之一。公司选择在年中公布这一批中期数据，或将为投资者评估其研发管线价值提供重要依据，并可能影响市场对该生物技术公司前景的判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128772341","title":"Tenaya Therapeutics Inc - TN-401不良事件呈无症状性，可自行缓解或对治疗产生应答","url":"https://stock-news.laohu8.com/highlight/detail?id=1128772341","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128772341?lang=zh_cn&edition=full","pubTime":"2026-05-15 18:04","pubTimestamp":1778839484,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics Inc 公布的数据显示，其药物TN-401在临床试验中观察到的不良事件均为无症状性质，并且这些事件最终自行缓解或对相应的治疗干预产生了良好应答。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199972376","title":"Tenaya 公司 Tn-401 药物 Ridge™-1 1B/2 期临床试验队列 1 和 2 中期积极数据：为 PKP2 相关 ARVC 成人患者持续减轻心律失常负担","url":"https://stock-news.laohu8.com/highlight/detail?id=1199972376","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199972376?lang=zh_cn&edition=full","pubTime":"2026-05-15 18:02","pubTimestamp":1778839361,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics 公司公布了其候选药物 Tn-401 在 Ridge™-1 1B/2 期临床试验中，针对 PKP2 基因相关致心律失常性右室心肌病成人患者的最新中期数据。来自队列 1 和队列 2 的初步结果显示，该疗法能够持续、显著地降低患者的心律失常负担。这一积极信号为后续研究奠定了重要基础，也增强了该创新疗法在治疗这一罕见且严重心脏病方面的潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518789128","title":"Tenaya Therapeutics(TNYA.US)：2024年Q4财报实现营收0美元，前值为0美元，预期值为100万美元；每股收益为-0.28美元，前值为-0.40美元，预期值为-0.31美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789128","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518789128?lang=zh_cn&edition=full","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics(TNYA.US)：2024年Q4财报实现营收0美元，前值为0美元，预期值为100万美元；每股收益为-0.28美元，前值为-0.40美元，预期值为-0.31美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153575348","title":"Tenaya Therapeutics 2024年第四季度GAAP每股亏损$0.28，优于预期的$0.31","url":"https://stock-news.laohu8.com/highlight/detail?id=1153575348","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153575348?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:10","pubTimestamp":1741637435,"startTime":"0","endTime":"0","summary":"Tenaya Therapeutics报告季度每股亏损$0.28，优于分析师一致预期的$0.31，超出9.68%。与去年同期每股亏损$0.40相比，这一数据增长了30%。以上内容来自Benzinga Earnings专栏，原文如下：Tenaya $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 9.68 percent. This is a 30 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNYA","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518719812","title":"Tenaya Therapeutics, Inc.股价飙升20.88% 市值涨1771.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518719812","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518719812?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613505,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Tenaya Therapeutics, Inc.股票出现波动，股价急速拉升20.88%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1916.39%、394.22%、52.01%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、珐博进，振幅分别为99.13%、98.72%、98.49%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213145abf2fc08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213145abf2fc08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","TNYA","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517366169","title":"Tenaya Therapeutics, Inc.盘中异动 早盘股价大涨5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517366169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517366169?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271506,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Tenaya Therapeutics, Inc.股票出现波动，股价快速拉升5.98%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Exicure, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为946.46%、104.14%、48.84%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223146abeb7788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223146abeb7788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","TNYA","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517910524","title":"Tenaya Therapeutics, Inc.股价上涨17.16% 市值涨700.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517910524?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185025,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Tenaya Therapeutics, Inc.股票出现波动，股价大幅拉升17.16%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为310.54%、251.30%、183.65%，振幅较大的相关个股有4D Molecular Therapeutics, Inc.、Plus Therapeutics, Inc.、Zura Bio Limited，振幅分别为8.56%、6.59%、5.61%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223026a260c6a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223026a260c6a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TNYA","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516765668","title":"Tenaya Therapeutics, Inc.盘中异动 下午盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516765668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516765668?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:01","pubTimestamp":1741032083,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时01分，Tenaya Therapeutics, Inc.股票出现波动，股价急速下跌5.21%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4574.50%、211.64%、182.38%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040401239637f5c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040401239637f5c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNYA","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513778971","title":"Tenaya Therapeutics, Inc.盘中异动 早盘急速下挫5.86%报1.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513778971?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:57","pubTimestamp":1740409072,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时57分，Tenaya Therapeutics, Inc.股票出现波动，股价急速下挫5.86%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为147.60%、62.30%、25.08%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225752a2521ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225752a2521ada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNYA","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513211380","title":"Tenaya Therapeutics, Inc.盘中异动 急速下跌5.29%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513211380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513211380?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:07","pubTimestamp":1740164864,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时07分，Tenaya Therapeutics, Inc.股票出现波动，股价急速下挫5.29%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Revolution Medicines Inc C/Wts 17/12/2026 、Invivyd, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为300.01%、247.92%、136.72%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030745988e17f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030745988e17f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNYA","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512677671","title":"Tenaya Therapeutics, Inc.盘中异动 股价大跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512677671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512677671?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:04","pubTimestamp":1739898265,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时04分，Tenaya Therapeutics, Inc.股票出现异动，股价快速跳水5.00%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Aditxt, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为472.65%、183.81%、154.85%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010425a24acd96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219010425a24acd96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511769982","title":"Tenaya Therapeutics, Inc.盘中异动 股价大涨5.10%报0.995美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511769982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511769982?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543539,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Tenaya Therapeutics, Inc.股票出现波动，股价急速拉升5.10%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1011.24%、361.73%、330.96%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Theratechnologies Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为20.20%、18.33%、15.20%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422321998858998&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422321998858998&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511579747","title":"Tenaya Therapeutics, Inc.盘中异动 大幅上涨5.09%报0.943美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511579747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511579747?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:22","pubTimestamp":1739474536,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时22分，Tenaya Therapeutics, Inc.股票出现异动，股价急速上涨5.09%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3178.22%、1971.21%、1233.53%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214032217a244e489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214032217a244e489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","TNYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510228355","title":"Tenaya Therapeutics, Inc.盘中异动 下午盘快速拉升5.62%报0.948美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510228355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510228355?lang=zh_cn&edition=full","pubTime":"2025-02-12 02:45","pubTimestamp":1739299505,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日02时45分，Tenaya Therapeutics, Inc.股票出现波动，股价大幅拉升5.62%。Tenaya Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.75%。其相关个股中，Omega Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3097.52%、1446.54%、485.18%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、72.23%、58.60%。Tenaya Therapeutics, Inc.公司简介：Tenaya Therapeutics Inc 是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212024505a2423137&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212024505a2423137&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TNYA","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tenayatherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0786},{"period":"1month","weight":-0.2001},{"period":"3month","weight":-0.3789},{"period":"6month","weight":-0.2615},{"period":"1year","weight":-0.6823},{"period":"ytd","weight":-0.2319}],"compareEarnings":[{"period":"1week","weight":0.0195},{"period":"1month","weight":0.0116},{"period":"3month","weight":0.0452},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tenaya Therapeutics, Inc.于2016年8月在特拉华州注册成立。该公司是一家临床前阶段的生物技术公司，专注于发现、开发和提供治疗心脏病的潜在驱动因素的治疗方法。公司正在从三个不同但相互关联的产品平台推进产品候选：基因治疗、细胞再生和精准医疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.091688},{"month":2,"riseRate":0.2,"avgChangeRate":-0.006231},{"month":3,"riseRate":0.4,"avgChangeRate":-0.077091},{"month":4,"riseRate":0.2,"avgChangeRate":0.069395},{"month":5,"riseRate":0.4,"avgChangeRate":0.046898},{"month":6,"riseRate":0.2,"avgChangeRate":-0.085773},{"month":7,"riseRate":0.6,"avgChangeRate":-0.018309},{"month":8,"riseRate":0.333333,"avgChangeRate":0.067589},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.104897},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.054665},{"month":11,"riseRate":0.4,"avgChangeRate":0.123533},{"month":12,"riseRate":0.2,"avgChangeRate":-0.128991}],"exchange":"NASDAQ","name":"Tenaya Therapeutics Inc","nameEN":"Tenaya Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tenaya Therapeutics Inc(TNYA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tenaya Therapeutics Inc(TNYA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tenaya Therapeutics Inc,TNYA,Tenaya Therapeutics Inc股票,Tenaya Therapeutics Inc股票老虎,Tenaya Therapeutics Inc股票老虎国际,Tenaya Therapeutics Inc行情,Tenaya Therapeutics Inc股票行情,Tenaya Therapeutics Inc股价,Tenaya Therapeutics Inc股市,Tenaya Therapeutics Inc股票价格,Tenaya Therapeutics Inc股票交易,Tenaya Therapeutics Inc股票购买,Tenaya Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tenaya Therapeutics Inc(TNYA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tenaya Therapeutics Inc(TNYA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}